|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
FDA Approvals: Glumetza, Nexavar, Micera
|
|
|
The FDA has approved a new strength for metformin HCl extended-release tablets, a new indication for sorafenib tosylate tablets, and methoxy polyethylene glycol-epoetin beta. Medscape Medical News
|
| 5. |
Hypertension, Dyslipidemia Linked to Nephropathy Risk in Type 1 Diabetes
|
|
|
Dyslipidemia and hypertension, as well as longer disease duration, elevated HbA1c level, and male gender, are all significant risk factors for diabetic nephropathy in patients with type 1 diabetes, according to a report in the October issue of Diabetes Care. Reuters Health Information
|
|
|